These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15033164)

  • 61. The dual neuroprotective-neurotoxic profile of cannabinoid drugs.
    Sarne Y; Asaf F; Fishbein M; Gafni M; Keren O
    Br J Pharmacol; 2011 Aug; 163(7):1391-401. PubMed ID: 21323910
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drug addiction.
    Justinova Z; Panlilio LV; Goldberg SR
    Curr Top Behav Neurosci; 2009; 1():309-46. PubMed ID: 21104390
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Signal transduction via cannabinoid receptors.
    Dalton GD; Bass CE; Van Horn CG; Howlett AC
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):422-31. PubMed ID: 19839935
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.
    Puighermanal E; Marsicano G; Busquets-Garcia A; Lutz B; Maldonado R; Ozaita A
    Nat Neurosci; 2009 Sep; 12(9):1152-8. PubMed ID: 19648913
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
    Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
    Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Protein kinases and addiction.
    Lee AM; Messing RO
    Ann N Y Acad Sci; 2008 Oct; 1141():22-57. PubMed ID: 18991950
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans.
    D'Souza DC; Pittman B; Perry E; Simen A
    Psychopharmacology (Berl); 2009 Mar; 202(4):569-78. PubMed ID: 18807247
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of novel RasGRF1 interacting partners by large-scale proteomic analysis.
    Lavagni P; Indrigo M; Colombo G; Martegani E; Rosenblum K; Gnesutta N; Zippel R
    J Mol Neurosci; 2009 Mar; 37(3):212-24. PubMed ID: 18607774
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transcriptomic and proteomic analyses of mouse cerebellum reveals alterations in RasGRF1 expression following in vivo chronic treatment with delta 9-tetrahydrocannabinol.
    Colombo G; Rusconi F; Rubino T; Cattaneo A; Martegani E; Parolaro D; Bachi A; Zippel R
    J Mol Neurosci; 2009 Feb; 37(2):111-22. PubMed ID: 18584336
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism.
    Daigle TL; Kwok ML; Mackie K
    J Neurochem; 2008 Jul; 106(1):70-82. PubMed ID: 18331587
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug-induced alterations in the extracellular signal-regulated kinase (ERK) signalling pathway: implications for reinforcement and reinstatement.
    Zhai H; Li Y; Wang X; Lu L
    Cell Mol Neurobiol; 2008 Feb; 28(2):157-72. PubMed ID: 18041576
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.
    Daigle TL; Kearn CS; Mackie K
    Neuropharmacology; 2008 Jan; 54(1):36-44. PubMed ID: 17681354
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade.
    Rubino T; Viganò D; Premoli F; Castiglioni C; Bianchessi S; Zippel R; Parolaro D
    Mol Neurobiol; 2006 Jun; 33(3):199-213. PubMed ID: 16954596
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ERK-dependent modulation of cerebellar synaptic plasticity after chronic Delta9-tetrahydrocannabinol exposure.
    Tonini R; Ciardo S; Cerovic M; Rubino T; Parolaro D; Mazzanti M; Zippel R
    J Neurosci; 2006 May; 26(21):5810-8. PubMed ID: 16723539
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
    Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
    J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.
    Jia W; Hegde VL; Singh NP; Sisco D; Grant S; Nagarkatti M; Nagarkatti PS
    Mol Cancer Res; 2006 Aug; 4(8):549-62. PubMed ID: 16908594
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protein phosphatase 2A-negative regulation of the protective signaling pathway of Ca2+/CaM-dependent ERK activation in cerebral ischemia.
    Zhao J; Wu HW; Chen YJ; Tian HP; Li LX; Han X; Guo J
    J Neurosci Res; 2008 Sep; 86(12):2733-45. PubMed ID: 18478546
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modulation of extracellular signal-regulated kinases cascade by chronic delta 9-tetrahydrocannabinol treatment.
    Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
    Mol Cell Neurosci; 2004 Mar; 25(3):355-62. PubMed ID: 15033164
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.